Deanna Cheek is a Nephrology physician. OpenAlex indexes 12 publications with 831 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2093 Henry Tecklenburg Dr
Suite 307
Charleston, SC 294145743
Telephone
843-573-0821Registry record last updated 21 Nov 2007.
Clinical trials
- African American Study of Kidney Disease and Hypertension ABPM Pilot Study
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year20231 payment
- Otsuka America Pharmaceutical, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.1%Calcium channel blocker24.1%Amlodipine Besylate84%Amlodipine-Valsartan16%Part D<11 patientsAngiotensin receptor blocker (ARB)14.7%Irbesartan79%Valsartan22%Part D<11 patients+ 5 more classes in this area
Other
8.7%Drugs for treatment of hyperkalemia and hyperphosphatemia8.7%Velphoro100%Part D<11 patientsMetabolism & gastrointestinal
4.4%Proton pump inhibitor2.5%Omeprazole100%Part D<11 patientsH2 blocker1.9%Famotidine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1994–2008 per NIH RePORTER. The latest:
- THE AASK AMBULATORY BP PILOT STUDY: THE EFFECTS OF RAMIPRIL ON NOCTURNAL BP
Medical University of South Carolina
FY2008$41,463M01RR001070
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Metabolic Syndrome, Proteinuria, and the Risk of Progressive CKD in Hypertensive African Americans
American Journal of Kidney Diseases
2008 - Glomerular filtration rate can be accurately predicted using lean mass measured by dual-energy X-ray absorptiometry
Nephrology Dialysis Transplantation
2005
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”